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Several human pathogens and the plant pathogen Agrobacterium
tumefaciens use a type IV secretion system for translocation of
effector proteins into host cells. How effector proteins are selected
for transport is unknown, but a C-terminal transport signal is
present in the proteins translocated by the A. tumefaciens VirBD4
type IV secretion system. We characterized this signal in the
virulence protein VirF by alanine scanning and further site-directed
mutagenesis. The Cre recombinase was used as a reporter to
measure the translocation efficiency of Cre–Vir fusions from A.
tumefaciens to Arabidopsis. The data unambiguously showed that
positive charge is an essential characteristic of the C-terminal
transport signal. We increased the sensitivity of this translocation
assay by modifying the Cre-induced readout in host cells from
kanamycin resistance to GFP expression. This improvement al-
lowed us to detect translocation of the VirD2 relaxase protein in
the absence of transferred DNA, showing that attachment to the
transferred DNA is not essential for transport by the VirBD4
system. We also found another translocated effector protein,
namely the VirD5 protein encoded by the tumor-inducing plasmid.
According to secondary structure predictions, the C termini of all
VirBD4-translocated proteins identified so far are unstructured;
however, they contain a characteristic hydropathic profile. Based
on sequence alignments and mutational analysis of VirF, we
conclude that the C-terminal transport signal for recruitment and
translocation of effector proteins by the A. tumefaciens VirBD4
system is hydrophilic and has a net positive charge with a consen-
sus motif of R-X(7)-R-X-R-X-R-X-X(n)>.
translocation signal  type IV secretion  Cre recombinase reporter assay for
translocation  VirF protein  effector protein
Certain bacterial pathogens use specialized secretion systemsthat span the bacterial envelope to inject effector proteins
directly into eukaryotic host cells. One such system, the type IV
secretion system (T4SS), is used by Agrobacterium tumefaciens
for the induction of the plant tumor crown gall in plants and by
pathogens such as Brucella spp., Bartonella spp., Helicobacter
pylori, and Legionella pneumophila to provoke disease in humans
and animals (1–4). This versatile family of T4SSs not only
transports effector proteins but also includes a large group that
is involved in conjugative DNA transfer within and between
bacterial species, as well as in interkingdom transfer to plants,
yeasts, and fungi (5–8). The translocated substrates have been
identified for some bacteria (1, 9, 10), but, in most cases, it is still
not known how the bacteria subvert host cells and cause disease.
A. tumefaciens causes crown gall disease on plants by trans-
ferring a nucleoprotein complex and several effector proteins by
means of its virBD4-encoded T4SS into host cells (11, 12). The
VirD2 protein initiates conjugative DNA processing of a region
of the tumor-inducing plasmid, the T region, resulting in release
of a single-stranded transferred DNA (T-DNA) molecule. The
VirD2 relaxase remains covalently associated to the 5 end of
the T-DNA and is thought to act as a pilot to mediate transfer
of the complex through the T4SS and into the host cell nucleus.
Subsequent expression of the genes located on this T-DNA
disturbs the plant’s hormonal balance, causing uncontrolled cell
division and development of a tumor. The ssDNA-binding
protein VirE2 is independently translocated into host cells (13,
14) and is thought to protect the T strand against nucleases (15).
In the plant cell, VirD2 and VirE2 together are thought to ensure
nuclear targeting of the complex by virtue of their nuclear
localization signals (16, 17). Translocation of VirF and VirE3 is
necessary for full virulence on some host plants. Although the
precise role of these effector proteins in the infection process has
not yet been elucidated, VirF is somehow involved in proteolytic
degradation of target proteins by the proteasome (18). The
VirBD4 secretion system is composed of the 11 VirB subunits
and the inner membrane protein VirD4. The architecture of the
secretion complex (19) and the pathway through which the
effector substrates pass are becoming clearer. Cascales and
Christie (14) recently demonstrated, in an elegant study using a
T-DNA immunoprecipitation assay, that the coupling protein
VirD4 is the first component of the T4SS to interact with the
T-DNAVirD2 transfer intermediate. The VirE2 protein inter-
acts at the cell poles of the bacterium with VirD4 (20), strongly
supporting the model that VirD4 is the cytoplasmic component
of the T4SS that sorts not only nucleoprotein complexes but also
the effector proteins for translocation and that T4SS are actually
committed protein translocation systems (21, 22). Translocation
of the effector proteins VirF, VirE2, and VirE3 is mediated by
a C-terminal transport signal (13, 20, 23, 24). Sequence com-
parison suggested that an RPR motif might play a role in
recognition by the secretion apparatus; however, it is not known
how the effector proteins and the nucleoprotein complex are
recognized by the T4SS.
Here, we report a detailed analysis of the VirF translocation
signal by using the previously developed Cre recombinase re-
porter assay for translocation (CRAfT) (13, 23), in which the
site-specific recombinase Cre is used as a reporter to detect
translocation of Vir proteins into host cells. We also provide
evidence for translocation of another effector protein, VirD5, as
well as for the relaxases VirD2, and MobA from IncQ plasmid
RSF1010 in the absence of their cognate DNA substrate by using
an optimized GFP reporter plant line. A consensus motif for the
transport signal of translocated proteins of the A. tumefaciens
T4SS is proposed.
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Materials and Methods
Bacterial Strains and Growth Conditions. Bacteria were grown in LC
medium (10 g/liter bacto-tryptone5 g/liter yeast extract8 g/liter
NaCl, pH 7) with appropriate antibiotics. A. tumefaciens strain
LBA1100 (25), containing octopine type pTiB6 with a complete
virulence (vir) region but lacking T-DNA and transfer functions,
was used for most transport experiments with A. thaliana root
explants. Selection conditions of the strains and methods for
introduction of plasmids are described in detail elsewhere (26).
In some experiments, LBA2587, a derivative of LBA1100 with
a precise deletion of virD4 (27), was used.
Plasmid Constructions. To create site-directed mutants of
Cre::virF42N (pSDM3155) (13, 26), we used the protocol
described by Sawano and Miyawaki (28). The Cre::VirF42N
fusion protein was chosen for mutagenesis studies because it
was the most efficiently transferred Cre::Vir protein analyzed
(13). Further details of the cloning procedures, creation of
targeted Cre fusions, sequences of oligonucleotides, plasmid,
and DNA sources can be found in Supporting Materials and
Methods and Tables 2 and 3 which are published as supporting
information on the PNAS web site. DNA sequences, encoding
the C-terminal 19 aa of VirF, 10 aa of VirF, 50 aa of VirD1,
VirD2, VirD3, VirD5, Ysa, Atu6154, and MobA, as well as
full-length VirD2, were translationally fused to cre in plasmid
pSDM3197 (26). All cre control and cre-vir genes used in this
study are expressed from the A. tumefaciens virF promoter
sequence, and the chimeric proteins contain an N-terminally
located simian virus 40 nuclear localization signal sequence to
ensure nuclear targeting after Vir-mediated translocation into
host cells. All plasmids were introduced into A. tumefaciens by
electroporation (29). Expression was verified by Western blot
analysis as described earlier (23).
Plant Material. Two different transgenic Arabidopsis thaliana
ecotype C24 lines were used for detection of translocation of
chimeric Cre-Vir proteins from A. tumefaciens. In line 3043 (13)
(Fig. 2, which is published as supporting information on the
PNAS web site) Cre-mediated excision results in expression of a
neomycin phosphotransferase (npt II) gene, leading to kanamy-
cin resistance. In this study, we isolated a second reporter plant
line that has GFP expression as a readout to visualize Cre
activity. A single-copy transgenic line was selected after A.
tumefaciens-mediated transformation of root explants with
pCB1 (30) and selection for phosphinothricin resistance (31)
(Fig. 2). Southern blot analysis confirmed the presence of a
single T-DNA insert, and the offspring of homozygous CB1
plants was used in further experiments.
Protein Translocation Experiments. Transformation of A. thaliana
roots is described elsewhere (23, 31). Briefly, seedlings from A.
thaliana 3043 or CB1 were grown for 10 days. Roots were
collected and precultured for 3 days, followed by a 3-day
cocultivation period with A. tumefaciens. The 3043 root explants
were transferred to fresh shoot induction medium containing 50
mgliter kanamycin and 100 mgliter timentin (23) to select for
Cre-mediated induction of npt II expression. Two Petri dishes,
each containing at least 200 root explants (accurately deter-
mined after distribution of the explants) were used per strain.
The number of kanamycin-resistant calli per root explant was
determined 2 weeks after cocultivation. The transfer efficiency
of Cre fusion proteins is expressed as percent of the control,
Cre::VirF42N, that contains the C-terminal 160 aa of WT VirF
fused to Cre, and which was included in each experiment to allow
comparison. A single-sample Student t test with a hypothetical
mean value of 100% was performed for each mutant to deter-
mine whether the average translocation efficiency of the mutant
differed significantly from WT (P  0.05). The GFP marker in
CB1 roots allowed assaying for translocation directly after
cocultivation by fluorescence microscopy (Leica MZ FLIII
microscope and a Sony 3CCD color video camera).
Results
Delimitation of the C-Terminal Translocation Signal of VirF. Previ-
ously, it was established that the A. tumefaciens effector proteins
VirE2, VirE3, and VirF possess a C-terminal transport signal
(13, 23, 24) in which the only apparent common element was an
RPR tripeptide. By using the CRAfT assay and A. thaliana
reporter line 3043, in which Cre-mediated excision of a lox-
f lanked DNA sequence by translocated Cre-Vir fusion proteins
from Agrobacterium is detected as kanamycin resistance (Fig. 2),
the translocation signal was reduced to the C-terminal 37 aa of
VirF (13). Here, we extended the analysis of N-terminal dele-
tions of VirF and found that the C-terminal 19 aa were still
sufficient to transfer Cre into 3043 host cells with an efficiency
of 25.5 5.4% (SE); n 6] of Cre::VirF42N (see Materials and
Methods for definition of transfer efficiency). We could not,
however, detect transfer of a Cre fusion with the C-terminal 10
aa to the kanamycin reporter line (see below for transfer by using
a more sensitive GFP reporter line). Importantly, there was no
transfer of Cre::VirF19C from virD4 mutant LBA2587 (27),
showing that translocation mediated by this short sequence also
still depends on the presence of an intact T4SS.
Truncation of the C terminus was found to have severe effects
on transfer efficiency. Removal of the last residue of VirF
resulted in an extreme decrease in transfer (by 96%; Table 1).
Transfer of a mutant lacking the last 3 aa was not detectable.
These data suggest that the last amino acid is critical, or that the
position of other residues from the C terminus is critical for
efficient signal recognition (see below).
Alanine Scanning and Site-Directed Mutagenesis Reveal the Impor-
tance of Positively Charged Residues in the C-Terminal Transport
Signal of VirF. Chou–Fasman secondary structure analysis of
VirE2, VirE3, and VirF predicts unstructured C termini. To gain
more insight into the nature of the C-terminal translocation
signal of VirF, we performed alanine scanning, replacing 15
residues in the C terminus of the chimeric protein
Cre::VirF42N independently by Ala by a primer mutagenesis
approach (28). The data of a large number of independent
cocultivation experiments (summarized in Table 1) unambigu-
ously showed that mutation of the Arg residues R187, R195,
R197, and R200 into Ala significantly decreased the transloca-
tion efficiency of VirF (by 85%, 84%, 60%, and 80%, respec-
tively); these Arg residues are therefore important for efficient
recognition by the transfer apparatus. We tested whether R173
and R177 located further from the C terminus were equally
important, but mutation of neither of these amino acids resulted
in a significant decrease in transfer. Although a single-sample
Student t test indicated that translocation of the P196A mutant
protein differed significantly from WT, the reduction by only
22% indicates that Pro is not a critical residue. Mutation of any
of the other residues did not result in a significant change in
translocation efficiency as compared with WT.
The data suggest that the four Arg residues in the C-terminal
20 aa of VirF are important for recognition by the VirBD4
T4SS, although R197 appears to be less important than the
other three. Conversion of the last 2 amino acid positions to
Ala did not lead to a decrease in transfer, whereas truncation
by removal of the C-terminal residue (Leu) dramatically
reduced transfer. This finding suggests that the presence of an
Arg residue at the 3 position (R200) from the C terminus
may play an important role in efficient signal recognition.
Given that positively charged Arg residues are an important
characteristic of the signal, we determined whether Arg could
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be replaced by another positively charged amino acid, Lys. As
shown in Table 1, replacement of the Arg residues at positions
R187, R195, R197, and R200 by Lys did not reduce the transfer
efficiency significantly, clearly indicating that positive charge
rather than the precise structure of the Arg residue itself is
important for signal recognition. In agreement with this idea,
replacement of an Arg residue by the acidic Asp residue
resulted in an even stronger decrease in transfer (especially for
R200) than mutation to Ala. Simultaneous mutation of R195
and R200 into Asp resulted in a complete loss of transfer (even
when tested by using the sensitive GFP reporter line described
below). These findings highlight the strong correlation be-
tween a positively charged C terminus and transfer ability.
Development of a Super-Sensitive Reporter Plant Line for CRAfT. To
develop a more sensitive and faster assay to detect protein
translocation, we isolated a reporter line of A. thaliana contain-
ing a single-copy insertion of pCB1 (30). CB1 (Fig. 2) allows the
use of GFP fluorescence as a readout for Cre-Vir transfer from
A. tumefaciens. In contrast to reporter line 3043, root explants
can be assayed for protein translocation immediately after the
3-day cocultivation period with A. tumefaciens. Fig. 1A gives an
impression of the efficiency with which Cre activity can be
visualized. Transformation of CB1 roots with a T-DNA con-
struct containing a cre gene behind a strong plant promoter
based on the mannopine synthase sequence [pBigMac-cre (32)]
resulted in high numbers of host cells expressing GFP 3 days
Table 1. Mutational analysis of the C-terminal transport signal of VirF
Mutation* Sequence of amino acids 173–202 n† Efficiency‡ P
WT VirF RPIARSIKTAHDDARAELMSADRPRSTRGL 10 100
Ala mutants
R173A APIARSIKTAHDDARAELMSADRPRSTRGL 3 69  21 0.2725
R177A RPIAASIKTAHDDARAELMSADRPRSTRGL 3 67  25 0.3207
D185A RPIARSIKTAHDAARAELMSADRPRSTRGL 4 78  9 0.10994
R187A RPIARSIKTAHDDAAAELMSADRPRSTRGL 4 15  3 0.0001
E189A RPIARSIKTAHDDARAALMSADRPRSTRGL 3 100  28 0.9895
L190A RPIARSIKTAHDDARAEAMSADRPRSTRGL 2 68  8 0.1524
M191A RPIARSIKTAHDDARAELASADRPRSTRGL 3 103  31 0.9271
S192A RPIARSIKTAHDDARAELMAADRPRSTRGL 2 69  14 0.2722
D194A RPIARSIKTAHDDARAELMSAARPRSTRGL 3 80  16 0.3559
R195A RPIARSIKTAHDDARAELMSADAPRSTRGL 7 16  3 0.0001
P196A RPIARSIKTAHDDARAELMSADRARSTRGL 3 78  0.1 0.0001
R197A RPIARSIKTAHDDARAELMSADRPASTRGL 6 40  10 0.0016
S198A RPIARSIKTAHDDARAELMSADRPRATRGL 3 124  23 0.4101
T199A RPIARSIKTAHDDARAELMSADRPRSARGL 2 74  3 0.071
R200A RPIARSIKTAHDDARAELMSADRPRSTAGL 3 20  11 0.0195
G201A RPIARSIKTAHDDARAELMSADRPRSTRAL 2 80  18 0.4696
L202A RPIARSIKTAHDDARAELMSADRPRSTRGA 2 93  13 0.6748
Arg mutants
R187D RPIARSIKTAHDDADAELMSADRPRSTRGL 3 10  2 0.0006
R187K RPIARSIKTAHDDAKAELMSADRPRSTRGL 2 57  13 0.1812
R195D RPIARSIKTAHDDARAELMSADDPRSTRGL 3 4  2 0.0003
R195K RPIARSIKTAHDDARAELMSADKPRSTRGL 3 72  24 0.3746
R197D RPIARSIKTAHDDARAELMSADRPDSTRGL 4 23  8 0.0025
R197K RPIARSIKTAHDDARAELMSADRPKSTRGL 2 65  9 0.1583
R200D RPIARSIKTAHDDARAELMSADRPRSTDGL 3 0.7  0.4 0.0001
R200K RPIARSIKTAHDDARAELMSADRPRSTKGL 2 76  13 0.3137
Double Arg mutants
R195197A RPIARSIKTAHDDARAELMSADAPASTRGL 3 0.5  0.3 0.0001
R195197D RPIARSIKTAHDDARAELMSADDPDSTRGL 3 6  4 0.0022
R195200D RPIARSIKTAHDDARAELMSADDPRSTDGL 3 0  0 0.0001
Other mutants
P196I RPIARSIKTAHDDARAELMSADRIRSTRGL 3 65  4 0.0121
R195197N RPIARSIKTAHDDARAELMSADNPNSTRGL 3 8  4 0.0022
L190M191G RPIARSIKTAHDDARAEGGSADRPRSTRGL 3 52  15 0.0875
P196S198I RPIARSIKTAHDDARAELMSADRIRITRGL 3 35  9 0.0187
C-terminal truncations
R200 Stop RPIARSIKTAHDDARAELMSADRPRST* 3 0  0 0.0001
G201 Stop RPIARSIKTAHDDARAELMSADRPRSTR* 3 5  3 0.001
L202 Stop RPIARSIKTAHDDARAELMSADRPRSTRG* 2 4  0.4 0.003
Transport experiments are performed as described in Materials and Methods.
*Mutations are indicatedbyaone-letter codeandposition followedby theaminoacid intowhich itwasmodified.
Stop, introduction of premature stop codon.
†Total number of independent transformation experiments.
‡Transfer efficiency is expressed as percentage of kanamycin-resistant calli per root explant of the WT control
(mean SE). A single-sample two-tailed Student t test was performed to determine the probability that transfer
of the mutant differs significantly from WT (P  0.05). The transfer efficiency of WT VirF in 10 independent
experiments was 0.54, 0.83, 0.76, 0.52, 0.28, 1.08, 0.94, 0.88, 1.14, and 0.81 kanamycin-resistant calli per root
explant.
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after cocultivation. Cocultivation with the negative control strain
lacking T-DNA but expressing Cre alone from the bacterial virF
promoter [LBA1100 (pSDM3197) (26)] rarely (1 in 5,000
explants) resulted in a GFP fluorescing host cell. In contrast,
protein translocation of Cre:VirF42N and Cre::VirF37C re-
sulted in high numbers of GFP fluorescing cells per root explant
(see Fig. 1A). Transport mediated by the C-terminal 19 aa of
VirF was reduced by 75% compared with transfer by the
VirF42N protein, in agreement with results described above
using the kanamycin reporter line 3043. A chimeric protein
consisting of the C-terminal 10 aa of VirF fused to Cre was able
to induce GFP expression in CB1 host cells, although we had
been unable to detect translocation of this chimeric protein into
3043 cells. This finding highlights that this regeneration-
independent reporter system can detect remarkably low levels of
translocation, and shows that a minimal signal for recognition by
the VirBD4 transport system must be present in this short 10-aa
sequence.
VirBD4-Dependent Translocation of Relaxase Proteins VirD2 and
MobA in the Absence of a DNA Substrate. According to a current
model, T4SSs are dedicated protein translocation machines that
have evolved to transfer also nucleoprotein complexes (4, 21).
The relaxase protein that is covalently bound to the 5 end of the
ssDNA molecule is thought to possess the T4SS transport signal
and thus act as a pilot for the complex. Therefore, we analyzed
translocation of the VirD2 and the MobA relaxase protein of
IncQ plasmid RSF1010, which can be mobilized by the VirBD4
T4SS (25), in the absence of bound DNA. We detected trans-
location of Cre::VirD2 in one experiment by using reporter plant
line 3043 with kanamycin resistance as a readout (nine kana-
mycin-resistant calli in 480 root explants, 0.8% of
Cre::VirF42N), but were unable to reproduce this result.
Furthermore, we did not find evidence for translocation of Cre
fused to the 50 C-terminal aa of VirD2. However, we were able
to reproducibly show translocation of a Cre::VirD2 fusion pro-
tein by using the GFP reporter system (Fig. 1A) in 20–30 cells
per 500 explants. During the course of our experiments, Dot
Icm-dependent translocation of the MobA protein from a Le-
gionella donor to an Escherichia coli recipient was reported (10).
Here, we obtained evidence for translocation of Cre fused to the
C-terminal 48 aa of MobA from A. tumefaciens strain LBA1100
to plant cells, both with reporter line 3043 [2  1.1% (SE); n 
3] of Cre::VirF42N), as well as with line CB1 (data not shown).
Translocation of both Cre::MobA48C and Cre::VirD2 was VirB
D4-dependent because transfer was not detected from virD4
mutant LBA2587. LBA1100 contains neither a T-DNA nor an
IncQ plasmid, indicating that VirD2 and MobA translocation can
occur in the absence of DNA transfer. The presence of an
RKRAR and an RQR sequence respectively in the C termini of
VirD2 and MobA, and a net positive charge of4 and2 in the
last 20 aa, respectively, are in agreement with the requirements
of the C-terminal T4SS signal as revealed by our analysis of VirF
(see above).
VirD5 Is a Transported Effector Protein. Based on the presence of
the RxR tripeptide in MobA and VirD2, respectively, and the
finding that P196 was not critical for translocation of VirF, we
searched the vir region of the Ti plasmid for genes encoding
proteins with a positively charged C terminus containing an RxR
motif, and selected VirD1 (RRR), VirD3 (RLR), VirD5 (RDR),
Atu6154 (RDRSR), and Ysa (RDR) (8) as candidates. Protein
fusions of the C-terminal 50 aa of these proteins to Cre were
expressed in LBA1100, as confirmed by Western blot analysis
(data not shown). Root explants of both A. thaliana 3043 and
CB1 were cocultivated with LBA1100 expressing the respective
fusion proteins, but we could not detect translocation of VirD1,
VirD3, and Ysa. VirD5 transport, however, was detected to both
reporter plant lines [3043: 26.6  0.4% (SE), n  2 of
Cre::VirF42N], which is consistent with earlier observations
(33) that VirD5 contains eukaryotic DNA binding motifs and
Fig. 1. Visualization of protein translocation into host cells and alignment of
transport signals. (A) Root explants ofA. thalianaGFP reporter line CB1 3 days
after cocultivation with A. tumefaciens (A1) containing a T-DNA vector with
the cre gene behind a strong plant promoter or expressing Cre or Cre–Vir
fusions from a bacterial promoter (A 2–6). (A2). Cre alone. (A3) Cre::VirF37C.
(A4) Cre::VirF19C. (A5) Cre::VirF10C. (A6) Cre::VirD2. (B) Protein alignment
[MultAlin, which can be accessed at http:prodes.toulouse.inra.frmultalin
multalin.html (39)] of theC-terminal 30 aaofA. tumefaciensVirF, VirE3, VirE2,
VirD5, and VirD2 from pTiB6, and Atu6154 from pTiC58, M. loti proteins
Msi059 andMsi061 and RSF1010MobA. (C) Kyte–Doolittle hydropathy plot of
the alignment in B.
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nuclear localization signal sequences, and may, therefore, play a
role in the host cell during the infection process.
In addition, we detected transport of the fusion with the
Atu6154 protein. This protein, which is encoded by the nopaline
pTiC58 plasmid, is closely related to the VirF protein of the
octopine Ti plasmid, but has a different function, because it
cannot complement for the absence of VirF (21).
The C Termini of VirBD4-Translocated Proteins Reveal a Consensus
Arg Motif and Show Similarity in Hydropathic Profile. By using
CRAfT, the VirD2, VirD5, VirE2, VirE3, VirF, Atu6154, and
MobA proteins have been shown to be translocated by the A.
tumefaciens T4SS directly into host cells. A recent study (27)
showed that Mesorhizobium loti contains a VirBD4 T4SS that
is implicated in nodulation processes on several leguminous host
plants. The CRAfT assay was used to show that two M. loti
proteins, Msi059 and Msi061, both of which are involved in
nodulation, can be translocated by the A. tumefaciens T4SS (27).
An alignment of the 30 C-terminal aa of these nine translocated
proteins (Fig. 1B) highlights the importance of Arg residues, and
suggests a consensus sequence of R-X(7)-R-X-R-X-R. The
incidence of Arg residues among the C-terminal 20 residues is
higher than expected for the Arg composition of A. tumefaciens
proteins (6.64%), and the net charge varies between1 and4.
Besides the resemblance in the presence of Arg residues in the
aligned proteins, the Kyte–Doolittle hydropathy profiles of the
C termini also show similarity (Fig. 1C). To analyze the impor-
tance of this characteristic profile, we constructed three mutants
in which the profile of the VirF C terminus was modified, without
changing the net charge; P196I, L190M191G, and P196S198I
(see Table 1 and Fig. 3, which is published as supporting
information on the PNAS web site). Although not significant for
L190M191G, transfer of P196I and P196S198I mutant pro-
teins was significantly reduced by 35% and 65%, respectively,
compared with WT. This result indicates that the presence of the
characteristic profile in the C terminus helps to ensure efficient
transfer, but that it is not essential for signal recognition.
The hydropathic profiles of the C termini of the other mutant
proteins used in this study were not changed compared with WT
VirF, except for R195197A. To find out whether modification
of charge andor profile in this mutant protein caused the
dramatic decrease in transfer efficiency, we created the R195
197N mutant protein that has a similar hydropathic profile (see
Fig. 3), but a net charge of 2 compared with WT. This mutant
protein was strongly reduced in transfer, indicating that charge
is more critical than the characteristic hydropathic profile for
efficient transfer. Regardless of changing the characteristic
profile, the C termini of the profile mutants are still hydrophilic.
The lack of detectable translocation of VirD1 and VirD3,
selected as candidate effectors based on the C-terminal RxR
motif, may be due to the hydrophobic character at their C
terminus. The striking resemblance in hydropathic profile be-
tween the translocated proteins suggests that the A. tumefaciens
C-terminal transport signal not only has an Arg-rich consensus
sequence but that it is also hydrophilic.
Discussion
A central question in T4SS biology is how this translocation
system can transfer both effector proteins and DNA molecules
from donor to recipient. In this respect, the A. tumefaciens
VirBD4 T4SS is an appealing focus for study because it
transfers both DNA molecules into host cells, and, independent
of these DNA molecules, the effector proteins VirE2, VirE3, and
VirF (13, 26).
Most bacterial protein secretion systems recognize their sub-
strates through a signal in the N terminus. There is a clear
consensus in the cleavable N-terminal signal peptide sequences
recognized by the Sec-dependent and twin Arg translocation
(TAT) systems (34, 35). So far, no consensus has been found to
define the N-terminal signal that is present in the effector
proteins recognized by the type III secretion system. In contrast,
the transport signal of the effectors VirE2, VirE3, and VirF of
the A. tumefaciens T4SS is located in the C terminus (13, 23, 24).
In this study, we identified VirD5 and Atu6154 encoded by the
nopaline type Ti plasmid as effector proteins of the Agrobacte-
rium transfer system, and we showed that both proteins also carry
a C-terminal transport signal. Preliminary data (A.C.V.,
T.A.G.S., A.O., and P.J.J.H., unpublished work) show that
VirD5 is targeted to the plant cell nucleus and that VirD5 is not
essential for tumor formation, but may, like VirF and VirE3, play
a role in optimizing the transfer process and thus enlarge host
range. Atu6154 is related to the octopine Ti plasmid VirF protein
but cannot complement a virF mutation (21). Possibly, the
nopaline pTi-encoded protein has adopted another function
during infection and will be an interesting subject for further
studies.
To define the C-terminal translocation signal of the A. tume-
faciens T4SS, we used a deletion and mutagenesis approach for
the effector protein VirF. Alanine scanning provided evidence
that Arg residues in the C-terminal part of the protein at
positions 187, 195, 197, and 200, but not 173 and 177, are
important for translocation. Substitution of any of the other
residues within the C-terminal 20 aa with Ala did not result in
a significant decrease of transfer. Subsequent site-directed mu-
tagenesis revealed that these important Arg residues could be
replaced with Lys, but not Asp, without significantly affecting
translocation efficiency. These data show an apparent correla-
tion of positive charge with transport function, and we propose
that the VirF signal is likely to interact with a complementary
charged domain in the coupling protein VirD4.
Interestingly, in the accompanying article, Nagai et al. (36)
performed a detailed analysis of the DotIcm-translocated
Legionella pneumophila RalF protein, and showed that a Leu
residue at the 3 position in the C terminus is critical for
transfer. Similarly, in the A. tumefaciens VirF protein, the Arg
residue at the 3 position is very important for transfer. In
contrast, Simone et al. (24) reported that the C-terminal 5 aa of
VirE2 are dispensable for transfer. Close inspection of the
sequence shows that these 5 aa do not contain a positively
charged residue, and that an Arg residue becomes located at the
3 position after removal of the C-terminal 5 aa of VirE2.
Replacement of the C-terminal residue L202 in VirF by Ala does
not affect translocation, showing that this is not a critical residue.
However, removal of L202, resulting in a protein that is trun-
cated by one amino acid led to an almost complete loss of
transfer. These findings suggest that critical residues for transfer
require at least two additional residues at the C terminus. Based
on our findings for the VirF signal and an alignment (Fig. 1 B and
C) of the C termini of the so-far-identified proteins, we extended
the RPR sequence predicted to be part of the transport signal
based on the effector proteins VirE2, VirE3, and VirF (13) to a
consensus R-X(7)-R-X-R-X-R-X-X(n)	 sequence that is hy-
drophilic and has a net positive charge. The maximum value of
n has to be determined experimentally because our data do not
allow us to draw conclusions about the maximum allowed
distance of the motif from the C terminus.
Accumulating evidence suggests that it is the coupling protein
that recruits both the protein substrates and the nucleoprotein
complex to the T4SS (4, 14, 20, 22, 37, 38), the latter by virtue
of the relaxase protein that is covalently bound to the DNA. Our
studies show that Cre::VirD2 chimeric proteins are translocated
into host cells in the absence of T-DNA, strongly suggesting that
the relaxase component VirD2 indeed provides the transport
signal for transfer of the nucleoprotein complex. Recently, it was
shown that the IncQ plasmid RSF1010 MobA relaxase is trans-
located from Legionella to E. coli by the DotIcm T4SS (10),
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suggesting that MobA, similar to VirD2, carries the transport
signal. Here, we show that the MobA protein can also be
translocated by the A. tumefaciens T4SS into plant cells. Indeed,
the MobA protein contains the C-terminal consensus sequence
and hydropathic profile present in the A. tumefaciens effector
proteins. Moreover, as the DNA binding and relaxase functions
are not present in these C-terminal 48 aa of MobA, we can now
definitely conclude that translocation of relaxase proteins such
as MobA and VirD2 from donor to (prokaryotic or eukaryotic)
recipient can occur, irrespective of whether they have a co-
valently bound DNA molecule attached.
Chou–Fasman secondary structure analysis predicts an un-
structured C terminus for the translocated A. tumefaciens pro-
teins, suggesting a mobile and open structure. This finding is in
line with the results described by Nagai et al. (36) in the
accompanying manuscript that indicate that the translocation
signal for recruitment of the RalF effector protein by the L.
pneumophila DotIcm system is disordered, and is thus probably
flexible. Besides, a long -helix upstream of the sequence that
contains the transport signal may be required to project the
signal for optimal interaction with the coupling protein and
the T4SS (36). The minimal information required for recogni-
tion of the VirF signal must be present in the C-terminal 10 aa
of VirF because those amino acids were able to translocate Cre
into host cells; however, the efficiency of translocation was
reduced dramatically compared with a 19-aa sequence. Besides
the absence of R187, a lack of structural information may be
the reason for the inefficient translocation. Similarly, the
Cre::VirD2–50C fusion may lack such features that resulted in
inefficient and undetectable transport. Small differences in other
properties, such as the spacing of the Arg residues, the prefer-
ence for Arg residues (even though Lys can replace these Arg
residues in VirF) or the characteristic hydrophilic profile may
influence the efficiency of translocation, and thereby create an
organized translocation of the different effector proteins during
infection. The fact that not all proteins with the features of the
A. tumefaciens T4SS transport signal are exported suggests that
either other so far unrecognized features may be concealed in
the T4SS signal or that additional properties in those proteins
may be incompatible with translocation. Interestingly, we were
unable to detect translocation of a Cre::GFP::VirF fusion pro-
tein from A. tumefaciens by using the sensitive GFP reporter line
(data not shown). This result is in line with an earlier suggestion
that GFP may block translocation at a step after recruitment to
VirD4 (20), and suggests that the T4SS may only transport
unfolded proteins.
The finding that two M. loti proteins that are involved in
nodulation can be translocated by the A. tumefaciens T4SS
system (27) is in line with the close evolutionary relatedness
between those species. In contrast, we were unable to detect
translocation by the A. tumefaciens VirBD4 system of the L.
pneumophila RalF protein (A.C.V. and A.d.D.-R., unpublished
data). Together, this result indicates that although there are
common features in C-terminal transport signals of different
T4SS, additional characteristics determine specificity for the
cognate T4SS and the VirD4 coupling factor. An intriguing
question then is how promiscuous plasmids, such as the IncQ
plasmids evolved to be able to hitchhike on different T4SSs. One
possibility is that the MobA protein of the incQ plasmid has
combined minimal information needed for secretion by different
T4SS. Otherwise, it may contain multiple C-terminal signals.
Further detailed analysis will have to show which is the case.
Further studies to the interaction of effector molecules with
components of the T4SS and the coupling protein will undoubt-
edly provide detailed insight into the molecular mechanism of
protein translocation and give direction to the development of
novel antimicrobials against pathogens that use a T4SS for
pathogenesis.
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